• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.

作者信息

Abdelhalim Ahmed, Barcos Maurice, Block Annemarie W, Sait Sheila N J, Starostik Petr, Wetzler Meir, Wang Eunice S

出版信息

Leuk Lymphoma. 2007 May;48(5):1053-6. doi: 10.1080/10428190701258370.

DOI:10.1080/10428190701258370
PMID:17487757
Abstract
摘要

相似文献

1
Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.达沙替尼治疗后费城染色体阳性中枢神经系统白血病的缓解
Leuk Lymphoma. 2007 May;48(5):1053-6. doi: 10.1080/10428190701258370.
2
Systemic dasatinib fails to prevent development of central nervous system progression in a patient with BCR-ABL unmutated Philadelphia chromosome-positive leukemia.在一名BCR-ABL未突变的费城染色体阳性白血病患者中，系统性使用达沙替尼未能预防中枢神经系统进展的发生。
Blood. 2009 May 14;113(20):5028-9. doi: 10.1182/blood-2008-11-191080.
3
Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid.达沙替尼治疗处于持久完全细胞遗传学缓解期的急变期慢性髓性白血病患者出现孤立性中枢神经系统复发：脑脊液中的药代动力学及ABL突变分析
Leuk Lymphoma. 2013 Jul;54(7):1557-9. doi: 10.3109/10428194.2012.745933. Epub 2012 Dec 22.
4
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
5
Philadelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia.
Blood. 2007 Oct 15;110(8):3086-7. doi: 10.1182/blood-2007-05-092437.
6
Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemia.异基因造血干细胞移植后达沙替尼维持治疗慢性髓性白血病孤立性中枢神经系统急变期。
Acta Haematol. 2013;130(2):111-4. doi: 10.1159/000347158. Epub 2013 Mar 29.
7
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.达沙替尼可穿过血脑屏障，是治疗中枢神经系统费城染色体阳性白血病的有效疗法。
Blood. 2008 Aug 15;112(4):1005-12. doi: 10.1182/blood-2008-02-140665. Epub 2008 May 13.
8
[Dasatinib is an efficient therapy for central nervous system Philadelphia chromosome-positive mixed phenotype acute leukemia].达沙替尼是治疗中枢神经系统费城染色体阳性混合表型急性白血病的有效疗法。
Zhonghua Xue Ye Xue Za Zhi. 2014 Nov;35(11):1016-7. doi: 10.3760/cma.j.issn.0253-2727.2014.11.015.
9
[Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].达沙替尼治疗伊马替尼耐药的BCR/ABL阳性白血病的疗效
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):581-6. doi: 10.7534/j.issn.1009-2137.2013.03.009.
10
[Pharmacological properties and clinical efficacy of dasatinib hydrate (Sprycel), an anticancer drug for chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia].达沙替尼水合物（施达赛）用于慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的药理特性及临床疗效
Nihon Yakurigaku Zasshi. 2009 Sep;134(3):159-67. doi: 10.1254/fpj.134.159.

引用本文的文献

1
Non-conducting functions of ion channels: The case of integrin-ion channel complexes.离子通道的非传导功能：整合素-离子通道复合物的情况。
Channels (Austin). 2022 Dec;16(1):185-197. doi: 10.1080/19336950.2022.2108565.
2
Primary Testicular and Cutaneous Philadelphia Chromosome Positive B-Cell Lymphoblastic Lymphoma: A Rare Case and Review.原发性睾丸和皮肤费城染色体阳性B细胞淋巴母细胞淋巴瘤：1例罕见病例及文献复习
Cancer Manag Res. 2022 Apr 21;14:1507-1514. doi: 10.2147/CMAR.S353022. eCollection 2022.
3
Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer's disease.
人脑中 KCNB1 通道的氧化作用和阿尔茨海默病小鼠模型。
Cell Death Dis. 2018 Jul 26;9(8):820. doi: 10.1038/s41419-018-0886-1.
4
Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report.达沙替尼作为慢性髓性白血病急变期合并中枢神经系统受累的挽救治疗：一例报告。
Oncol Lett. 2015 Apr;9(4):1957-1961. doi: 10.3892/ol.2015.2928. Epub 2015 Feb 3.
5
Philadelphia chromosome-positive acute lymphoblastic leukemia with extramedullary and meningeal relapse after allogeneic hematopoietic stem cell transplantation that was successfully treated with dasatinib.费城染色体阳性急性淋巴细胞白血病，异基因造血干细胞移植后发生髓外和脑膜复发，使用达沙替尼成功治疗。
Springerplus. 2014 Apr 5;3:177. doi: 10.1186/2193-1801-3-177. eCollection 2014.
6
Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib.伊马替尼耐药慢性髓性白血病的靶向治疗：聚焦达沙替尼。
Onco Targets Ther. 2009 Feb 18;2:83-94. doi: 10.2147/ott.s3971.
7
Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.伊马替尼耐药慢性髓性白血病（CML）：发病机制的当前概念及新出现的药理学方法
Biologics. 2007 Dec;1(4):433-48.
8
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.间变性淋巴瘤激酶：在癌症发病机制中的作用及用于治疗的小分子抑制剂研发
Expert Rev Anticancer Ther. 2009 Mar;9(3):331-56. doi: 10.1586/14737140.9.3.331.